High HLA-DP expression and graft-versus-host disease

New England Journal of Medicine

Volumn 373, Issue 7, 2015, Pages 599-609

  Petersdorf, Effie W ^a,b   Malkki, Mari ^a   O'hUigin, Colm ^c   Carrington, Mary ^c,d   Gooley, Ted ^a   Haagenson, Michael D ^e   Horowitz, Mary M ^f   Spellman, Stephen R ^e   Wang, Tao ^f   Stevenson, Philip ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^d HARVARD UNIVERSITY   (United States)

^e Center for International Blood and Marrow Transplant Research   (United States)

^f MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DP ANTIGEN; HLA DPB1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; HLA-DPB1 ANTIGEN;

ACUTE GRAFT VERSUS HOST DISEASE; ARTICLE; CONTROLLED STUDY; DONOR SELECTION; FEMALE; GENE DOSAGE; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; GENETIC VARIABILITY; HAPLOTYPE; HISTOCOMPATIBILITY COMPLEX; HLA DP GENE; HLA DPB1 GENE; HLA MATCHING; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; RECURRENCE RISK; RISK ASSESSMENT; ADOLESCENT; ADULT; ADVERSE EFFECTS; GENETICS; GENOTYPE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TEST; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; REGULATORY SEQUENCE; SINGLE NUCLEOTIDE POLYMORPHISM; UNRELATED DONORS; YOUNG ADULT;

ADOLESCENT; ADULT; FEMALE; GENETIC LINKAGE; GENOTYPE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HLA-DP BETA-CHAINS; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS; REGULATORY SEQUENCES, NUCLEIC ACID; UNRELATED DONORS; YOUNG ADULT;

EID: 84941622235     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1500140     Document Type: Article

References (29)

1. Cutler C, Antin JH. Manifestations and treatment of acute graft-versus-host disease. In: Appelbaum FR, Forman SJ, Negrin RS, Blume KG, eds. Thomas' hematopoietic cell transplantation. 4th ed. Chichester, United Kingdom: Wiley-Blackwell, 2009:1287-303.
2. Martin PJ. Increased disparity for minor histocompatibility antigens as a potential cause of increased GVHD risk in marrow transplantation from unrelated donors compared with related donors. Bone Marrow Transplant 1991; 8: 217-23.
3. Sasazuki T, Juji T, Morishima Y, et al. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. N Engl J Med 1998; 339: 1177-85.
4. Lee SJ, Klein J, Haagenson M, et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 2007; 110: 4576-83.
5. Kawase T, Morishima Y, Matsuo K, et al. High-risk HLA allele mismatch combinations responsible for severe acute graftversus-host disease and implication for its molecular mechanism. Blood 2007; 110: 2235-41.
6. Mickelson E, Petersdorf EW. Histo-compatibility. In: Appelbaum FR, Forman SJ, Negrin RS, Blume KG, eds. Thomas' hematopoietic cell transplantation. 4th ed. Chichester, United Kingdom: Wiley-Blackwell, 2009:145-62.
7. Pidala J, Lee SJ, Ahn KW, et al. Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation. Blood 2014; 124: 2596-606.
8. Petersdorf EW, Hansen JA, Martin PJ, et al. Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation. N Engl J Med 2001; 345: 1794-800.
9. Zino E, Frumento G, Marktel S, et al. A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation. Blood 2004; 103: 1417-24.
10. Van Rood JJ, van Leeuwen A. Major and minor histocompatibility systems in man and their importance in bone marrow transplantation. In: Dupont B, Good RA, eds. Immunobiology of bone marrow transplantation. New York: Gruen & Stratton, 1976:103-10.
11. Edwards JA, Durant BM, Jones DB, Evans PR, Smith JL. Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression. J Immunol 1986; 137: 490-7.
12. Guardiola J, Maffei A. Control of MHC class II gene expression in autoimmune, infectious, and neoplastic diseases. Crit Rev Immunol 1993; 13: 247-68.
13. Petersdorf EW, Gooley T, Malkki M, et al. The biological significance of HLA-DP gene variation in haematopoietic cell transplantation. Br J Haematol 2001; 112: 988-94.
14. Shaw BE, Mayor NP, Russell NH, et al. Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles. Leukemia 2010; 24: 58-65.
15. Fernández-Viña MA, Klein JP, Haagenson M, et al. Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation. Blood 2013; 121: 4603-10.
16. Fleischhauer K, Shaw BE, Gooley T, et al. Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study. Lancet Oncol 2012; 13: 366-74.
17. Apps R, Qi Y, Carlson JM, et al. Influence of HLA-C expression level on HIV control. Science 2013; 340: 87-91.
18. Petersdorf EW, Gooley TA, Malkki M, et al. HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation. Blood 2014; 124: 3996-4003.
19. Kamatani Y, Wattanapokayakit S, Ochi H, et al. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet 2009; 41: 591-5.
20. Thomas R, Thio CL, Apps R, et al. A novel variant marking HLA-DP expression levels predicts recovery from hepatitis B virus infection. J Virol 2012; 86: 6979-85.
21. Petersdorf EW, Malkki M, Gooley TA, et al. MHC-resident variation affects risks after unrelated donor hematopoietic cell transplantation. Sci Transl Med 2012; 4: ra101.
22. Malkki M, Petersdorf EW. Genotyping of single nucleotide polymorphisms by 5′ nuclease allelic discrimination. Methods Mol Biol 2012; 882: 173-82.
23. Moran D, Morishima S, Malkki M, Petersdorf EW. Identification of the MICA∗070 allele by sequencing and phasing. Hum Immunol 2013; 74: 557-61.
24. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008; 3: 1101-8.
25. Horowitz MM, Gale RP, Sondel PM, et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555-62.
26. Thus KA, Ruizendaal MT, de Hoop TA, et al. Refinement of the definition of permissible HLA-DPB1 mismatches with predicted indirectly recognizable HLA-DPB1 epitopes. Biol Blood Marrow Transplant 2014; 20: 1705-10.
27. Rutten CE, van Luxemburg-Heijs SAP, Halkes CJM, et al. Patient HLA-DP-specific CD4+ T cells from HLA-DPB1-mismatched donor lymphocyte infusion can induce graft-versus-leukemia reactivity in the presence or absence of graft-versus-host disease. Biol Blood Marrow Transplant 2013; 19: 40-8.
28. Rutten CE, van Luxemburg-Heijs SA, van der Meijden ED, et al. Both permissive and nonpermissive HLA-DPB1 mismatches can induce polyclonal HLA-DPB1 specific immune responses in vivo and in vitro. Blood 2010; 115: 151-3.
29. Stevanovic S, van Bergen CA, van Luxemburg-Heijs SA, et al. HLA class II upregulation during viral infection leads to HLA-DP-directed graft-versus-host disease after CD4+ donor lymphocyte infusion. Blood 2013; 122: 1963-73.